ELISABETH ROBINSON: Open Payments
NPI 1922511708 · WESTBROOK, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$847 in 36 payments from 17 companies in 2025. Trend: 2023 $154 · 2024 $758 · 2025 $847
Food & beverage: $847
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $127 |
| Daiichi Sankyo Inc. | 4 | $90 |
| Janssen Biotech, Inc. | 3 | $84 |
| Incyte Corporation | 3 | $80 |
| Merck Sharp & Dohme LLC | 4 | $68 |
| Novartis Pharmaceuticals Corporation | 4 | $68 |
| GENZYME CORPORATION | 2 | $55 |
| Stemline Therapeutics Inc. | 3 | $55 |
| Novocure Inc. | 1 | $41 |
| GlaxoSmithKline, LLC. | 1 | $29 |
Products named: EPKINLY, ERLEADA, ENHERTU, KEYTRUDA, WAYRILZ, KISQALI, Optune Lua (NovoTTF-200T), Orserdu.
Industry payments across ME — which companies pay providers there.
